DOLIVER ADVISORS, LP

Position in IBRX — ImmunityBio, Inc.

CIK 938077 HOUSTON, TX

Position in IBRX

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$875,500

+$492,000 QoQ

Shares Held

100,000

+100.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#118

of 401 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

DOLIVER ADVISORS, LP holds $1,521,600 across 3 Biotechnology names. IBRX ranks #1 (57.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IBRX	ImmunityBio, Inc. This page	100,000	$875,500
2	VRDN	Viridian Therapeutics, Inc.\DE	30,000	$551,100
3	ONCY	Oncolytics Biotech Inc	100,000	$95,000

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$875,500	100,000	+100.0%	Shares	Sole	2026-07-10
2026-03-31	$383,500	50,000	—	Shares	Sole	2026-04-08
No filing history on record for this holder in this stock.